eXoZymes
Monrovia
About eXoZymes
eXoZymes specializes in the design of enzymes and the construction of truly cell-free enzymatic pathways that can run continuously and unassisted outside of living cells, avoiding many of the issues that other synthetic biology companies face when attempting to scale cell-based or immobilized biomanufacturing technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.1M
- Funding stage: IPO
- Last round: Grant (Jun 2025)
- Ticker: nasdaq:EXOZ
- Website: exozymes.comblogexozymes
Industries & Categories
Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/exozymes-796 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.